These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12729646)

  • 1. New fibrinolytic agents: benzothiophene derivatives as inhibitors of the t-PA-PAI-1 complex formation.
    De Nanteuil G; Lila-Ambroise C; Rupin A; Vallez MO; Verbeuren TJ
    Bioorg Med Chem Lett; 2003 May; 13(10):1705-8. PubMed ID: 12729646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a small molecule PAI-1 inhibitor, ZK4044.
    Liang A; Wu F; Tran K; Jones SW; Deng G; Ye B; Zhao Z; Snider RM; Dole WP; Morser J; Wu Q
    Thromb Res; 2005; 115(4):341-50. PubMed ID: 15668194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ; Boon GI; Jansen JW; Bouma BN
    Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of pyrrolin-2-one compounds, a series of plasminogen activator inhibitor-1 inhibitors.
    Miyazaki H; Ogiku T; Sai H; Moritani Y; Ohtani A; Ohmizu H
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):979-85. PubMed ID: 19721260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pyrrolin-2-one derivatives synthesized by a new practical method as inhibitors of plasminogen activator inhibitor-1 (PAI-1).
    Miyazaki H; Miyake T; Terakawa Y; Ohmizu H; Ogiku T; Ohtani A
    Bioorg Med Chem Lett; 2010 Jan; 20(2):546-8. PubMed ID: 19969458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model.
    Kandadai MA; Meunier J; Lindsell CJ; Shaw GJ; Elkind MS
    Curr Neurovasc Res; 2012 Aug; 9(3):207-13. PubMed ID: 22621227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic activities of epi-sesamin in vitro and in vivo.
    Ku SK; Kim JA; Han CK; Bae JS
    Am J Chin Med; 2013; 41(6):1313-27. PubMed ID: 24228603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood.
    Rupin A; Gaertner R; Mennecier P; Richard I; Benoist A; De Nanteuil G; Verbeuren TJ
    Thromb Res; 2008; 122(2):265-70. PubMed ID: 18177924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
    Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
    Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
    Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitro.
    Shohet RV; Spitzer S; Madison EL; Bassel-Duby R; Gething MJ; Sambrook JF
    Thromb Haemost; 1994 Jan; 71(1):124-8. PubMed ID: 8165630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells.
    Kugiyama K; Sakamoto T; Misumi I; Sugiyama S; Ohgushi M; Ogawa H; Horiguchi M; Yasue H
    Circ Res; 1993 Aug; 73(2):335-43. PubMed ID: 8330376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
    Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 1,4-diphenylbutadiene derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.
    Miyazaki H; Sai H; Ohmizu H; Murakami J; Ohtani A; Ogiku T
    Bioorg Med Chem; 2010 Mar; 18(5):1968-79. PubMed ID: 20138768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.